Integrative Biology of Emerging Infectious Diseases (IBEID) / Principal investigators
Medical and Scientific Department of the Institut Mérieux
17 Rue Bourgelat – 69002 Lyon (France)
Research area of the Unit
Institut Merieux is a holding company, mobilizing through its 5 companies (BioMerieux, Transgene, MérieuxNutriScience, ABL-Merieux and Merieux Development), nearly 10,000 people worldwide. It is present in approximately 40 countries and has annual revenues exceeding 1.3 billion euro. Institut Mérieux is committing its experience in industrial biology to serve medicine and public health across the globe. Especially dedicated to the fight against infectious diseases and cancers, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition.
Christine M’Rini is the Scientific Director of the Institut Mérieux. The Medical and Scientific Department of the Institut Mérieux is in charge of the definition, implementation and management of transversal, R&D programs, at the interface of the Institut Mérieux companies, particularly in the areas of infectious diseases, cancer, cardiovascular diseases and food safety but also in the areas of biomarkers and personalized medicine, new technologies and nutrition on health.